| Print
BeOne Medicines Ltd (ONC)
American Depository ReceiptThis share can be held in a Dealing accountSIPP
Company profile
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
Address
c/o Mourant Ozannes Corporate Services (Cayman) Li
94 Solaris Avenue, Camana Bay
Grand Cayman
CYM
KY1-1108
Telephone
+1 857 3025189
Forecast key dates
| Name | Key Date |
|---|---|
| BeOne Medicines Ltd Third Quarter Earnings Conference Call for 2026 | 2026-11-06T08:00:00 |
| BeOne Medicines Ltd Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| BeOne Medicines Ltd Second Quarter Earnings Conference Call for 2026 | 2026-08-06T08:00:00 |
| BeOne Medicines Ltd Second Quarter Earnings Results for 2026 | 2026-08-06T00:00:00 |
| BeiGene Ltd Annual General Meeting for 2026 | 2026-05-21T08:30:00 |
| BeiGene Ltd First Quarter Earnings Conference Call for 2026 | 2026-05-07T08:00:00 |
| BeiGene Ltd First Quarter Earnings Results for 2026 | 2026-05-07T00:00:00 |
| BeiGene Ltd Fourth Quarter Earnings Conference Call for 2025 | 2026-02-27T08:00:00 |
| BeiGene Ltd Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
| BeiGene Ltd Annual Report for 2025 | 2026-02-27T00:00:00 |
| 44th Annual J.P. Morgan Healthcare Conference | 2026-01-13T07:30:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.